共 22 条
[1]
INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT
[J].
JOURNAL OF UROLOGY,
1995, 153 (03)
:934-941
[5]
DUCROCQ V, 1994, 5 WORLD C GEN APPL L, V22, P51
[6]
DUCROCQ V, 1996, GENET SEL EVOL, V28, P509
[7]
Ducrocq V., 1998, 6 WORLD C GEN APPL L, P447
[8]
Gamerman D., 1997, MARKOV CHAIN MONTE C
[9]
Ibrahim J.G., 2001, BAYESIAN SURVIVAL AN, DOI DOI 10.1007/978-1-4757-3447-8
[10]
ADJUVANT CHEMOTHERAPY OF SUPERFICIAL TRANSITIONAL CELL BLADDER-CARCINOMA - PRELIMINARY-RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH ON TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN HYDROCHLORIDE, ETHOGLUCID AND TRANS-URETHRAL RESECTION ALONE-R
[J].
JOURNAL OF UROLOGY,
1984, 132 (02)
:258-262